Lutetium-177 Therapy Reshapes the Protein Landscape of Neuroendocrine Tumors
Proteomic profiling of GOT1 neuroendocrine tumors after lutetium-177 DOTATATE therapy reveals suppressed invasion pathways and altered p53 and stress signaling ...
Proteomic profiling of GOT1 neuroendocrine tumors after lutetium-177 DOTATATE therapy reveals suppressed invasion pathways and altered p53 and stress signaling ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.